Abstract
This Health Industry Insights report provides guidance on life science IT
spending trends based on a detailed evaluation of survey results. This research
further evaluates how spending sentiment and behavior differ by various
industry subsegments based on company size (1,000 or more employees and fewer
than 1,000 employees), organization type (pharmaceutical, biotech, government,
academia/research hospital, and CRO/CMO), and functional area (basic research,
preclinical drug development, clinical trials, manufacturing/distribution, and
sales and marketing). Health Industry Insights' Leading Indicators in Life
Science
IT Spending Survey is a quarterly research effort that probes end-user opinions
throughout the life science value chain on planned IT spending, technology
adoption attitudes, perspectives on leading vendors, and other IT-related
topics. This data was gathered via a Web-based survey, which yielded 178
participants, 62% of whom are manager level or above within their respective
organizations.
Eric Newmark, a research manager at Health Industry Insights, stated, "IT
spending in the life sciences remains strong, with 35% of the market expecting
to increase overall IT spend during 2008. As cost reduction becomes more
critical, companies are moving toward COTS applications that can be more easily
outsourced. They are also avoiding customization at all costs and implementing
corporatewide standardization and rationalization initiatives."
View Cart
